What does access to various hemato-oncology therapies look like today, and what is the situation of unmet needs of hemato-oncology patients in Poland?
A lot has happened for hematooncology patients in recent years. We are chasing Europe and the world. And we can indeed say that we are treating our hematology patients better and better. Even the recent changes in the reimbursement list bring something new again - bispecific antibodies - that's acute in follicular lymphoma. These changes make us very happy, but the o...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].